JP2011512817A - クロストリジウム・ディフィシル胞子に対する抗体及びその使用 - Google Patents

クロストリジウム・ディフィシル胞子に対する抗体及びその使用 Download PDF

Info

Publication number
JP2011512817A
JP2011512817A JP2010548830A JP2010548830A JP2011512817A JP 2011512817 A JP2011512817 A JP 2011512817A JP 2010548830 A JP2010548830 A JP 2010548830A JP 2010548830 A JP2010548830 A JP 2010548830A JP 2011512817 A JP2011512817 A JP 2011512817A
Authority
JP
Japan
Prior art keywords
seq
isolated antibody
protein
clostridium difficile
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010548830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011512817A5 (https=
Inventor
ラジュ ラジャゴパル，
アイ‐ピン ウェイ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of JP2011512817A publication Critical patent/JP2011512817A/ja
Publication of JP2011512817A5 publication Critical patent/JP2011512817A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1282—Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/067—Pancreatitis or colitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2010548830A 2008-02-28 2009-02-25 クロストリジウム・ディフィシル胞子に対する抗体及びその使用 Pending JP2011512817A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3227008P 2008-02-28 2008-02-28
PCT/US2009/035050 WO2009108652A1 (en) 2008-02-28 2009-02-25 Antibodies to clostridium difficile spores and uses thereof

Publications (2)

Publication Number Publication Date
JP2011512817A true JP2011512817A (ja) 2011-04-28
JP2011512817A5 JP2011512817A5 (https=) 2012-04-12

Family

ID=41016450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010548830A Pending JP2011512817A (ja) 2008-02-28 2009-02-25 クロストリジウム・ディフィシル胞子に対する抗体及びその使用

Country Status (9)

Country Link
US (2) US8697374B2 (https=)
EP (1) EP2271366A4 (https=)
JP (1) JP2011512817A (https=)
KR (1) KR20100126760A (https=)
CN (1) CN101980723A (https=)
AU (1) AU2009219358A1 (https=)
BR (1) BRPI0906060A2 (https=)
CA (1) CA2714720A1 (https=)
WO (1) WO2009108652A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528715A (ja) * 2011-09-15 2014-10-30 ロサンゼルス バイオメディカル リサーチ インスティテュート アットハーバー− ユーシーエルエー メディカル センター ＣｏｔＨを用いたムコール菌症の免疫療法および診断法
JP2015517658A (ja) * 2012-05-11 2015-06-22 テックラブ，インコーポレーテッド クロストリジウム・ディフィシル（Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅ）・リボタイプ０２７の診断マーカーとしての細胞壁タンパク質ＣｗｐＶ（ＣＤ０５１４）
JP2015529677A (ja) * 2012-09-19 2015-10-08 ノバルティス アーゲー ワクチンとしてのＣｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅポリペプチド

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126670A2 (en) * 2009-03-27 2010-11-04 Gojo Industries, Inc. Compositions and methods for screening and using compounds antagonizing spore-surface interactions
CN102533867A (zh) * 2010-12-10 2012-07-04 西北民族大学 一种艰难梭菌a毒素的类毒素的制备方法
US20120276059A1 (en) 2011-04-29 2012-11-01 Techlab, Inc. Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease
US10295535B2 (en) * 2011-04-29 2019-05-21 Techlab, Inc. Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease
PL2758432T3 (pl) * 2011-09-16 2019-08-30 Ucb Biopharma Sprl Przeciwciała neutralizujące przeciw głównym egzotoksynom tcda i tcdb z clostridium difficile
US10364298B2 (en) 2011-11-18 2019-07-30 National Research Council Of Canada Clostridium difficile lipoteichoic acid and uses thereof
CN102590515B (zh) * 2012-01-13 2014-07-30 张春华 艰难梭菌外毒素a检测试剂盒及组成该试剂盒的单克隆抗体
AR090219A1 (es) 2012-03-02 2014-10-29 Regeneron Pharma Anticuerpos humanos frente a toxinas de clostridium difficile
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
CN109776676A (zh) * 2012-11-28 2019-05-21 Cnj控股公司 针对艰难梭菌的抗体
CA2909636C (en) * 2013-04-19 2023-08-22 Dena Lyras Methods and compositions for the treatment and/or prophylaxis of clostridium difficile associated disease
US10890583B2 (en) * 2014-04-01 2021-01-12 Institut Pasteur Predictive value of Clostridium difficile-specific immune response for recurrence and disease outcome
JP6397939B2 (ja) 2014-06-09 2018-09-26 スリーエム イノベイティブ プロパティズ カンパニー アッセイ装置及び標的分析種の検出方法
WO2016127102A2 (en) 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
WO2017051413A1 (en) * 2015-09-21 2017-03-30 4C Diagnostics Ltd. Stool specimen collecting, sampling and diagnosing means and methods thereof
KR20220041072A (ko) * 2019-06-05 2022-03-31 엘아이브이 프로세스, 인크. 클로스트리듐 디피실에 대한 앱타머
CN111948388B (zh) * 2020-08-18 2022-03-22 山东农业大学 一种检测腐败梭菌的胶体金试纸条及其制备方法和应用
WO2023039159A2 (en) 2021-09-09 2023-03-16 Abel Santos Ernesto Inhibitors of c. difficile spore germination
CN119751687B (zh) * 2024-12-26 2025-09-26 杭州医学院 识别艰难梭菌谷氨酸脱氢酶中线性b细胞抗原表位的驼源单域抗体ga4及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002188A1 (en) * 1997-07-11 1999-01-21 The Arizona Board Of Regents On Behalf Of The University Of Arizona Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis
US20050220783A1 (en) * 1999-11-01 2005-10-06 Mucovax Holding B.V. Antibody production in farm animals

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879218A (en) 1982-09-13 1989-11-07 Virginia Tech Intellectual Properties, Inc. Antibody for C.difficile
US4530833A (en) 1982-09-13 1985-07-23 Wilkins Tracy D Toxins and antibodies of C. difficile
US4533630A (en) 1982-09-13 1985-08-06 Wilkins Tracy D Toxins and antibodies of C. difficile
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8426464D0 (en) 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
US4863852A (en) 1985-07-03 1989-09-05 Virginia Tech Intellectual Properties, Inc. Method of detecting, isolating and purifying clostridium difficile toxin A and its receptors
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
US5231003A (en) 1990-05-11 1993-07-27 Cambridge Bioscience Corporation Monoclonal antibodies specific for toxin b of clostridium difficile
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0585287T3 (da) 1990-07-10 2000-04-17 Cambridge Antibody Tech Fremgangsmåde til fremstilling af specifikke bindingsparelementer
CA2095633C (en) 1990-12-03 2003-02-04 Lisa J. Garrard Enrichment method for variant proteins with altered binding properties
EP1820858B1 (en) 1991-03-01 2009-08-12 Dyax Corporation Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US5610023A (en) 1995-03-31 1997-03-11 Lee Laboratories, Inc. Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
US5753517A (en) 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US7179611B2 (en) 1997-02-10 2007-02-20 Bd Lee Laboratories Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A
US5965375A (en) 1997-04-04 1999-10-12 Biosite Diagnostics Diagnostic tests and kits for Clostridium difficile
US5876960A (en) 1997-08-11 1999-03-02 The United States Of America As Represented By The Secretary Of The Army Bacterial spore detection and quantification methods
US6733760B1 (en) 1999-04-09 2004-05-11 Techlab, Inc. Recombinant toxin A/toxin B vaccine against Clostridium difficile
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
DE60025945T2 (de) 1999-11-01 2006-09-28 Mucovax Holding B.V. Herstellung von antikörpern in mammarsekreten von zuchttieren
US6509196B1 (en) 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
GB0007263D0 (en) 2000-03-24 2000-05-17 Imperial College Peptides
US6498041B1 (en) 2000-08-18 2002-12-24 Echo Technologies, Inc. Optical sensors for rapid, sensitive detection and quantitation of bacterial spores
US6815178B1 (en) 2001-11-19 2004-11-09 Antony R. Shoaf Endospore detection method
US7306930B2 (en) 2001-11-30 2007-12-11 California Institute Of Technology Method bacterial endospore quantification using lanthanide dipicolinate luminescence
US7428045B2 (en) 2002-01-10 2008-09-23 Chemimage Corporation Raman spectral analysis of pathogens
WO2003065009A2 (en) 2002-02-01 2003-08-07 California Institute Of Technology Methods and apparatus for assays of bacterial spores
US20030175318A1 (en) 2002-03-06 2003-09-18 Schilling Amanda S. Application of germination solution improved efficacy of biological decontamination
US20040033546A1 (en) 2002-04-10 2004-02-19 The Trustees Of Columbia University In The City Of New York Novel microarrays and methods of use thereof
US7608419B2 (en) 2003-11-13 2009-10-27 California Institute Of Technology Method and apparatus for detecting and quantifying bacterial spores on a surface
WO2004069848A2 (en) 2003-01-28 2004-08-19 Diversa Corporation Amidases, nucleic acids encoding them and methods for making and using them
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US20060275920A1 (en) 2005-06-01 2006-12-07 Petrilla John F Apparatus and method for discriminating among lateral flow assay test indicators

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999002188A1 (en) * 1997-07-11 1999-01-21 The Arizona Board Of Regents On Behalf Of The University Of Arizona Hen egg yolk antibodies to clostridium difficile antigens and use in therapy for pseudomembranous colitis
US20050220783A1 (en) * 1999-11-01 2005-10-06 Mucovax Holding B.V. Antibody production in farm animals

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6013044116; Ａｐｐｌ．　Ｅｎｖｉｒｏｎ．　Ｍｉｃｒｏｂｉｏｌ．，　１９９７，　６３（２），　ｐｐ．４８２-４８７ *
JPN6013044117; 'Ｄａｔａｂａｓｅ　ＤＤＢＪ／ＥＭＢＬ／ＧｅｎＢａｎｋ　［ｏｎｌｉｎｅ］，　Ａｃｃｅｓｓｉｎ　Ｎｏ．ＹＰ＿００１０８７５０２，　＜ｈｔｔｐ：／／ｗｗｗ．ｎｃｂｉ．ｎｌｍ．ｎｉｈ．ｇｏｖ／ｐｒｏｔｅｉｎ／' ［ｒｅｔｒｉｅｖｅｄ　ｏｎ　２０１３-０８-２９］，　ＳＥＢＡＩＨＩＡ　Ｍ．　ｅｔ　ａｌ．，　Ｄｅｆｉｎｉｔｉｏｎ：　ｈｙｐｏｔｈｅｔｉｃａｌ　ｐｒｏｔｅｉｎ　ＣＤ１０２１　［Ｃｌｏｓｔｒｉｄｉｕｍ *
JPN6013044119; 'Ｄａｔａｂａｓｅ　ＤＤＢＪ／ＥＭＢＬ／ＧｅｎＢａｎｋ　［ｏｎｌｉｎｅ］，　Ａｃｃｅｓｓｉｎ　Ｎｏ．ＹＰ＿００１０８７５１７，　＜ｈｔｔｐ：／／ｗｗｗ．ｎｃｂｉ．ｎｌｍ．ｎｉｈ．ｇｏｖ／ｐｒｏｔｅｉｎ／' ［ｒｅｔｒｉｅｖｅｄ　ｏｎ　２０１３-０８-２９］，　ＳＥＢＡＩＨＩＡ　Ｍ．　ｅｔ　ａｌ．，　Ｄｅｆｉｎｉｔｉｏｎ：　ｃｅｌｌ　ｓｕｒｆａｃｅ　ｐｒｏｔｅｉｎ　（ｐｕｔａｔｉｖｅ　Ｎ-ａｃｅｔｙｌｍｕ *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014528715A (ja) * 2011-09-15 2014-10-30 ロサンゼルス バイオメディカル リサーチ インスティテュート アットハーバー− ユーシーエルエー メディカル センター ＣｏｔＨを用いたムコール菌症の免疫療法および診断法
JP2015517658A (ja) * 2012-05-11 2015-06-22 テックラブ，インコーポレーテッド クロストリジウム・ディフィシル（Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅ）・リボタイプ０２７の診断マーカーとしての細胞壁タンパク質ＣｗｐＶ（ＣＤ０５１４）
JP2015529677A (ja) * 2012-09-19 2015-10-08 ノバルティス アーゲー ワクチンとしてのＣｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅポリペプチド

Also Published As

Publication number Publication date
EP2271366A4 (en) 2012-06-20
CA2714720A1 (en) 2009-09-03
KR20100126760A (ko) 2010-12-02
WO2009108652A1 (en) 2009-09-03
CN101980723A (zh) 2011-02-23
US20110183360A1 (en) 2011-07-28
EP2271366A1 (en) 2011-01-12
BRPI0906060A2 (pt) 2015-12-01
US8697374B2 (en) 2014-04-15
US20140335543A1 (en) 2014-11-13
AU2009219358A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
JP2011512817A (ja) クロストリジウム・ディフィシル胞子に対する抗体及びその使用
JP6622363B2 (ja) 抗リポアラビノマンナン抗体及び当該抗体を用いた抗酸菌症のイムノアッセイ
CN103582651A (zh) 识别人类乳突病毒(hpv)l2蛋白质的单克隆抗体及使用其的测定hpv中和抗体的效价的方法
US9052314B2 (en) Biomarkers for detecting the presence of bacteria
Lee et al. Characterization of chicken-derived antibody against Alpha-Enolase of Streptococcus pneumoniae
US20210214420A1 (en) Methods and compositions for pertussis diagnosis
Hannachi et al. Enhancing the detection of Toxoplasma gondii via an anti-SAG1 scFv-alkaline phosphatase immunoconjugate
US20230408517A1 (en) Anti-severe acute respiratory syndrome coronavirus antibodies
KR102244121B1 (ko) 브루셀라균의 omp28에 특이적으로 결합하는 단일클론항체, 상기 항체를 생산하는 하이브리도마 세포주 및 이의 용도
KR101851332B1 (ko) 스타필로코커스 아우레우스에 특이적인 신규한 단클론 항체, 이를 생산하는 하이브리도마, 이를 포함하는 검출용 조성물, 검출 방법 및 검출 키트
KR20160072516A (ko) 스타필로코커스 아우레우스에 특이적인 신규한 단클론 항체, 이를 생산하는 하이브리도마, 이를 포함하는 검출용 조성물, 검출 방법 및 검출 키트
US20080317742A1 (en) Biomarkers of francisella infection
JP6407990B2 (ja) アウグリン免疫学的検定
RU2588480C2 (ru) Антитело против липоарабиноманнана и иммунологический анализ инфекции, вызываемой кислотоустойчивыми бактериями, с использованием антитела
WO2014188763A1 (en) An antibody that binds to leptospiral antigen
WO2003013601A1 (en) Toxin associated with sudden infant death syndrome, and uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120220

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120220

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130903

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140225